| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 16 | 2025 | 112 | 6.240 |
Why?
|
| Vascular Endothelial Growth Factor A | 15 | 2025 | 179 | 5.810 |
Why?
|
| Ependymoglial Cells | 8 | 2025 | 32 | 3.750 |
Why?
|
| Diabetes Mellitus, Experimental | 8 | 2023 | 98 | 3.030 |
Why?
|
| Integrases | 12 | 2016 | 39 | 2.420 |
Why?
|
| Retina | 17 | 2026 | 445 | 2.400 |
Why?
|
| Retinal Neurons | 6 | 2017 | 13 | 2.040 |
Why?
|
| Hypoxia | 6 | 2025 | 90 | 1.950 |
Why?
|
| Retinal Pigment Epithelium | 13 | 2022 | 99 | 1.930 |
Why?
|
| Retinal Degeneration | 13 | 2026 | 156 | 1.620 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2025 | 22 | 1.590 |
Why?
|
| Mice | 53 | 2026 | 4802 | 1.580 |
Why?
|
| Animals | 60 | 2026 | 10684 | 1.430 |
Why?
|
| Mice, Knockout | 32 | 2026 | 874 | 1.380 |
Why?
|
| Retinal Vessels | 6 | 2017 | 75 | 1.370 |
Why?
|
| Blood-Retinal Barrier | 4 | 2021 | 27 | 1.290 |
Why?
|
| Signal Transduction | 10 | 2025 | 1469 | 1.260 |
Why?
|
| Photoreceptor Cells, Vertebrate | 6 | 2025 | 67 | 1.210 |
Why?
|
| Retinal Rod Photoreceptor Cells | 11 | 2026 | 98 | 1.130 |
Why?
|
| Retinopathy of Prematurity | 3 | 2017 | 40 | 1.120 |
Why?
|
| Recombination, Genetic | 5 | 2016 | 64 | 1.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 56 | 1.000 |
Why?
|
| Retinal Cone Photoreceptor Cells | 9 | 2026 | 131 | 0.990 |
Why?
|
| Macular Degeneration | 6 | 2018 | 85 | 0.950 |
Why?
|
| Electroretinography | 18 | 2023 | 180 | 0.950 |
Why?
|
| Mice, Transgenic | 17 | 2017 | 513 | 0.840 |
Why?
|
| Eye Proteins | 10 | 2016 | 207 | 0.800 |
Why?
|
| Promoter Regions, Genetic | 6 | 2010 | 344 | 0.730 |
Why?
|
| Receptor, trkB | 1 | 2021 | 9 | 0.700 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 52 | 0.680 |
Why?
|
| Neuroglia | 2 | 2019 | 30 | 0.660 |
Why?
|
| Choroidal Neovascularization | 4 | 2013 | 11 | 0.650 |
Why?
|
| Light | 10 | 2013 | 118 | 0.630 |
Why?
|
| Choroid | 2 | 2010 | 21 | 0.630 |
Why?
|
| Tomography, Optical Coherence | 3 | 2019 | 96 | 0.610 |
Why?
|
| Photoreceptor Cells | 4 | 2023 | 36 | 0.600 |
Why?
|
| Retinal Neovascularization | 4 | 2013 | 21 | 0.590 |
Why?
|
| Wet Macular Degeneration | 1 | 2019 | 9 | 0.590 |
Why?
|
| Neuroprotection | 1 | 2019 | 14 | 0.590 |
Why?
|
| Gene Targeting | 2 | 2016 | 21 | 0.540 |
Why?
|
| bcl-X Protein | 2 | 2008 | 35 | 0.530 |
Why?
|
| Cell Survival | 8 | 2025 | 419 | 0.520 |
Why?
|
| Ischemia | 3 | 2014 | 83 | 0.510 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 87 | 0.500 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 94 | 0.480 |
Why?
|
| Disease Models, Animal | 11 | 2018 | 1507 | 0.470 |
Why?
|
| Chloride Channels | 3 | 2010 | 4 | 0.470 |
Why?
|
| Cells, Cultured | 6 | 2021 | 1022 | 0.450 |
Why?
|
| Apoptosis | 6 | 2019 | 780 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 13 | 2026 | 1653 | 0.380 |
Why?
|
| Oxidative Stress | 6 | 2022 | 677 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 254 | 0.350 |
Why?
|
| Radiation Injuries, Experimental | 3 | 2011 | 31 | 0.340 |
Why?
|
| Mullerian Ducts | 1 | 2010 | 3 | 0.330 |
Why?
|
| Humans | 19 | 2025 | 28851 | 0.330 |
Why?
|
| Capillary Permeability | 4 | 2019 | 56 | 0.320 |
Why?
|
| Autophagy | 3 | 2017 | 77 | 0.310 |
Why?
|
| Rod Opsins | 2 | 2006 | 14 | 0.300 |
Why?
|
| Doxycycline | 4 | 2014 | 19 | 0.280 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 15 | 0.280 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 404 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 5 | 2014 | 270 | 0.270 |
Why?
|
| Gene Expression | 7 | 2015 | 417 | 0.260 |
Why?
|
| beta-Galactosidase | 3 | 2014 | 24 | 0.260 |
Why?
|
| Bestrophins | 4 | 2016 | 6 | 0.260 |
Why?
|
| Rats | 5 | 2021 | 1588 | 0.260 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2019 | 57 | 0.250 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2026 | 3 | 0.240 |
Why?
|
| Genetic Techniques | 1 | 2006 | 12 | 0.240 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2011 | 59 | 0.240 |
Why?
|
| Triiodothyronine | 1 | 2025 | 27 | 0.230 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2025 | 25 | 0.230 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 37 | 0.230 |
Why?
|
| Gene Deletion | 5 | 2017 | 120 | 0.220 |
Why?
|
| Membrane Proteins | 4 | 2014 | 485 | 0.220 |
Why?
|
| Vision, Ocular | 2 | 2015 | 27 | 0.220 |
Why?
|
| Transcription Factors | 3 | 2012 | 523 | 0.210 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 39 | 0.200 |
Why?
|
| Cilia | 2 | 2014 | 42 | 0.190 |
Why?
|
| Autophagy-Related Protein 7 | 3 | 2017 | 3 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 154 | 0.190 |
Why?
|
| Psychotherapy, Group | 1 | 2021 | 17 | 0.180 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 24 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 122 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2018 | 247 | 0.170 |
Why?
|
| Military Personnel | 1 | 2021 | 51 | 0.170 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2019 | 3 | 0.170 |
Why?
|
| Veterans | 1 | 2021 | 69 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 71 | 0.170 |
Why?
|
| Superoxide Dismutase | 3 | 2016 | 71 | 0.170 |
Why?
|
| Tight Junctions | 2 | 2011 | 29 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 2 | 2019 | 80 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2015 | 49 | 0.160 |
Why?
|
| Inflammation | 2 | 2019 | 667 | 0.160 |
Why?
|
| Cytokine Receptor gp130 | 2 | 2010 | 5 | 0.160 |
Why?
|
| Animals, Newborn | 2 | 2011 | 182 | 0.160 |
Why?
|
| Cytoprotection | 2 | 2010 | 24 | 0.160 |
Why?
|
| Cone Opsins | 1 | 2019 | 7 | 0.150 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 11 | 0.150 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 465 | 0.150 |
Why?
|
| Protein Transport | 4 | 2014 | 158 | 0.150 |
Why?
|
| Retinoids | 2 | 2015 | 38 | 0.150 |
Why?
|
| Ubiquitin-Activating Enzymes | 2 | 2015 | 4 | 0.140 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2015 | 34 | 0.140 |
Why?
|
| Cell Death | 6 | 2017 | 119 | 0.140 |
Why?
|
| Epithelium, Corneal | 1 | 2018 | 14 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2018 | 27 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 36 | 0.140 |
Why?
|
| Corneal Diseases | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 35 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 61 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2012 | 515 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 278 | 0.140 |
Why?
|
| DNA Fragmentation | 2 | 2008 | 18 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 43 | 0.130 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2017 | 1 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 7 | 0.130 |
Why?
|
| Bevacizumab | 1 | 2018 | 106 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2017 | 20 | 0.130 |
Why?
|
| Color Vision Defects | 1 | 2017 | 12 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 120 | 0.130 |
Why?
|
| Mitochondria | 2 | 2026 | 408 | 0.130 |
Why?
|
| Intravitreal Injections | 2 | 2014 | 34 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2017 | 72 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 215 | 0.120 |
Why?
|
| Male | 13 | 2017 | 13921 | 0.120 |
Why?
|
| Plasmids | 2 | 2008 | 126 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 163 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 477 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2018 | 265 | 0.120 |
Why?
|
| Dark Adaptation | 1 | 2015 | 13 | 0.120 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2011 | 7 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 82 | 0.110 |
Why?
|
| Geographic Atrophy | 1 | 2014 | 5 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 54 | 0.110 |
Why?
|
| Rats, Inbred BN | 2 | 2011 | 70 | 0.110 |
Why?
|
| Opsins | 2 | 2011 | 19 | 0.110 |
Why?
|
| Biomarkers | 2 | 2017 | 776 | 0.110 |
Why?
|
| Antimutagenic Agents | 1 | 2014 | 1 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 67 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 634 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 28 | 0.110 |
Why?
|
| Mutagenesis | 1 | 2014 | 46 | 0.100 |
Why?
|
| Cobalt | 1 | 2014 | 18 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 148 | 0.100 |
Why?
|
| Ketocholesterols | 1 | 2013 | 1 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 9 | 0.100 |
Why?
|
| Ischemic Preconditioning | 2 | 2011 | 4 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 787 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Lysosomes | 1 | 2013 | 56 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 135 | 0.090 |
Why?
|
| Female | 10 | 2017 | 15624 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 251 | 0.090 |
Why?
|
| Lentivirus | 1 | 2011 | 16 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 24 | 0.090 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2011 | 1 | 0.090 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2011 | 10 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 8 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2011 | 17 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2017 | 50 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 51 | 0.090 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2011 | 17 | 0.090 |
Why?
|
| Retinal Diseases | 1 | 2012 | 47 | 0.090 |
Why?
|
| Dextrans | 1 | 2011 | 23 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 157 | 0.090 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2011 | 18 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 328 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 198 | 0.080 |
Why?
|
| Leukostasis | 1 | 2010 | 3 | 0.080 |
Why?
|
| Antioxidants | 1 | 2012 | 224 | 0.080 |
Why?
|
| Capillaries | 1 | 2010 | 33 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 147 | 0.080 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 13 | 0.080 |
Why?
|
| Occludin | 1 | 2009 | 12 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 32 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 82 | 0.080 |
Why?
|
| Phototherapy | 1 | 2009 | 28 | 0.080 |
Why?
|
| Neurons | 1 | 2012 | 297 | 0.080 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2009 | 12 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 250 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2009 | 27 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2011 | 255 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 129 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 490 | 0.070 |
Why?
|
| Fluorescein Angiography | 3 | 2014 | 18 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2009 | 109 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 93 | 0.070 |
Why?
|
| Cell Line | 3 | 2015 | 700 | 0.070 |
Why?
|
| Rhodopsin | 3 | 2013 | 40 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2013 | 71 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 66 | 0.060 |
Why?
|
| Retinal Bipolar Cells | 1 | 2006 | 6 | 0.060 |
Why?
|
| Mosaicism | 1 | 2006 | 13 | 0.060 |
Why?
|
| Pyruvic Acid | 1 | 2026 | 19 | 0.060 |
Why?
|
| Time Factors | 2 | 2011 | 1613 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 8 | 0.060 |
Why?
|
| Blastocyst | 1 | 2006 | 6 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 137 | 0.060 |
Why?
|
| Transgenes | 1 | 2006 | 63 | 0.060 |
Why?
|
| Glycolysis | 1 | 2026 | 96 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2025 | 155 | 0.050 |
Why?
|
| Sirolimus | 2 | 2015 | 76 | 0.050 |
Why?
|
| Oxidants | 1 | 2022 | 31 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2022 | 36 | 0.050 |
Why?
|
| Heme | 1 | 2022 | 91 | 0.050 |
Why?
|
| Arrestin | 2 | 2011 | 11 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2011 | 29 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2013 | 202 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2015 | 668 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 463 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2011 | 585 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 354 | 0.030 |
Why?
|
| Ophthalmoscopes | 1 | 2016 | 1 | 0.030 |
Why?
|
| Ophthalmoscopy | 1 | 2016 | 6 | 0.030 |
Why?
|
| Ion Channels | 1 | 2016 | 28 | 0.030 |
Why?
|
| Sf9 Cells | 1 | 2015 | 1 | 0.030 |
Why?
|
| Spodoptera | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 9 | 0.030 |
Why?
|
| Retinaldehyde | 1 | 2015 | 7 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 57 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Pericytes | 1 | 2014 | 17 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 553 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 66 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 416 | 0.030 |
Why?
|
| Rod Cell Outer Segment | 1 | 2014 | 42 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 150 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 257 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 17 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2013 | 23 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 22 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 69 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 39 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2013 | 7 | 0.020 |
Why?
|
| Beclin-1 | 1 | 2013 | 5 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 137 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 33 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 38 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 77 | 0.020 |
Why?
|
| Vitamin A | 1 | 2013 | 32 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 125 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 145 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2012 | 3 | 0.020 |
Why?
|
| Glutathione Synthase | 1 | 2012 | 4 | 0.020 |
Why?
|
| Aorta | 1 | 2013 | 124 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 72 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 685 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2013 | 97 | 0.020 |
Why?
|
| Catalase | 1 | 2012 | 49 | 0.020 |
Why?
|
| Receptors, Kainic Acid | 1 | 2012 | 1 | 0.020 |
Why?
|
| Connexins | 1 | 2012 | 3 | 0.020 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2012 | 9 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 31 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2012 | 17 | 0.020 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 51 | 0.020 |
Why?
|
| Gene Library | 1 | 2012 | 45 | 0.020 |
Why?
|
| Netrin-1 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2012 | 65 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 65 | 0.020 |
Why?
|
| Brimonidine Tartrate | 1 | 2011 | 2 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 126 | 0.020 |
Why?
|
| Transducin | 1 | 2011 | 13 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2011 | 10 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2011 | 13 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 292 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 133 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 74 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 118 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 739 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 124 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 277 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 292 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 554 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 461 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 5 | 0.020 |
Why?
|
| Night Vision | 1 | 2010 | 7 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 237 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 233 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 612 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2009 | 7 | 0.020 |
Why?
|
| Retinitis Pigmentosa | 1 | 2009 | 33 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 97 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2009 | 16 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 21 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 25 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 57 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 82 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 2065 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 916 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 867 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2009 | 218 | 0.020 |
Why?
|
| Insulin | 1 | 2008 | 325 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 471 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 1016 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 5598 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 8024 | 0.010 |
Why?
|